Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1987 Feb;60(2):239–245.

Influence of reserpine on in vivo localization of injected lymph node cells in the mouse.

A Bellavia, H S Micklem
PMCID: PMC1453222  PMID: 3817871

Abstract

The effects of reserpine, and other agents that affect the storage and availability of 5-hydroxytryptamine (5HT), on the localization of injected 51Cr-labelled syngeneic lymph node cells have been investigated. A high dose (5 mg/kg) of reserpine to the recipients reduced localization in the lymph nodes and prevented the usual accumulation of lymphocytes in lymph nodes draining the site of an antigen (sheep erythrocytes: SE) injection. These effects were partially reversible by the monoamine oxidase inhibitor nialamide. This dose of reserpine produced deep sedation throughout the period of the experiment. Lower doses, up to 2.5 mg/kg, produced little sedation and had no effect on the localization of lymphocytes. Other workers had previously reported reduced localization of cells in delayed-type hypersensitivity (DTH) lesions after treatment of the recipients with 5 mg/kg reserpine, and had interpreted this in terms of a role of 5HT in promoting vascular permeability and egress of blood cells. The effect of lower doses of reserpine was not reported. We suggest that the effects on cell localization in both sets of experiments may have been secondary to the general state of sedation and not attributable to a direct local influence of 5HT. Other effects of reserpine included prolonged retention of lymphocytes in lungs and blood, and a reduction of cellularity and DNA synthesis in the thymus, spleen and lymph nodes.

Full text

PDF
239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askenase P. W., Bursztajn S., Gershon M. D., Gershon R. K. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J Exp Med. 1980 Nov 1;152(5):1358–1374. doi: 10.1084/jem.152.5.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BURN J. H., RAND M. J. The action of sympathomimetic amines in animals treated with reserpine. J Physiol. 1958 Dec 4;144(2):314–336. doi: 10.1113/jphysiol.1958.sp006104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bellavia A., Franklin V., Micklem H. S. Effects of dextran sulphate and heparin on lymphocyte localization: lack of involvement of complement and other plasma proteolytic systems. Int J Immunopharmacol. 1980;2(4):311–320. doi: 10.1016/0192-0561(80)90031-4. [DOI] [PubMed] [Google Scholar]
  4. Bellavia A., Micklem H. S. T lymphocytes and thymocytes with different localization properties separated by nylon-wool filtration. Transplantation. 1977 Mar;23(3):290–292. [PubMed] [Google Scholar]
  5. DRASKOCI M., JANKOVIC B. D. INVOLUTION OF THYMUS AND SUPPRESSION OF IMMUNE RESPONSES IN RATS TREATED WITH RESERPINE. Nature. 1964 Apr 25;202:408–409. doi: 10.1038/202408a0. [DOI] [PubMed] [Google Scholar]
  6. Freitas A. A., De Sousa M. Control mechanism of lymphocyte traffic. A study of the action of two sulfated polysaccharides on the distribution of 51Cr- and [3H]adenosine-labeled mouse lymph node cells. Cell Immunol. 1977 Jun 1;31(1):62–76. doi: 10.1016/0008-8749(77)90007-7. [DOI] [PubMed] [Google Scholar]
  7. Galli S. J., Hammel I. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science. 1984 Nov 9;226(4675):710–713. doi: 10.1126/science.6494907. [DOI] [PubMed] [Google Scholar]
  8. Gershon R. K., Askenase P. W., Gershon M. D. Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions. J Exp Med. 1975 Sep 1;142(3):732–747. doi: 10.1084/jem.142.3.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hay J. B., Hobbs B. B. The flow of blood to lymph nodes and its relation to lymphocyte traffic and the immune response. J Exp Med. 1977 Jan 1;145(1):31–44. doi: 10.1084/jem.145.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Inchley C. J., Micklem H. S., Barrett J., Hunter J., Minty C. Age-related changes in localization of injected radiolabelled lymphocytes in the lymph nodes of antigen-stimulated mice. Clin Exp Immunol. 1976 Nov;26(2):286–294. [PMC free article] [PubMed] [Google Scholar]
  11. Izumi F., Oka M., Yoshida H., Imaizumi R. Stimulatory effect of reserpine on monoamine oxidase in guinea pig heart. Biochem Pharmacol. 1969 Jul;18(7):1739–1748. doi: 10.1016/0006-2952(69)90163-4. [DOI] [PubMed] [Google Scholar]
  12. Jansson S. E. Effect of chlorpromazine, mepyramine, prenylamine and reserpine of 5-hydroxytryptamine content and fine structure of rat peritoneal mast cells incubated in vitro. Acta Physiol Scand. 1970 Mar;78(3):420–430. doi: 10.1111/j.1748-1716.1970.tb04678.x. [DOI] [PubMed] [Google Scholar]
  13. Kostrzewa R. M., Jacobowitz D. M. Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev. 1974 Sep;26(3):199–288. [PubMed] [Google Scholar]
  14. Mekori Y. A., Weitzman G. L., Galli S. J. Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells. J Exp Med. 1985 Dec 1;162(6):1935–1953. doi: 10.1084/jem.162.6.1935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Polák L., Turk J. L. The effect of antihypertensive agents on the peripheral manifestation of allergic and other inflammatory reactions in the skin. Int Arch Allergy Appl Immunol. 1969;36(5):442–449. doi: 10.1159/000230764. [DOI] [PubMed] [Google Scholar]
  16. Pritchard H., Micklem H. S. Immune responses in congenitally thymus-less mice. I. Absence of response to oxazolone. Clin Exp Immunol. 1972 Jan;10(1):151–161. [PMC free article] [PubMed] [Google Scholar]
  17. Ranne G. H., Smith M. E., Ford W. L. Lymphocyte migration into cell-mediated immune lesions is inhibited by trypsin. Nature. 1977 Jun 9;267(5611):520–522. doi: 10.1038/267520a0. [DOI] [PubMed] [Google Scholar]
  18. SHORE P. A. Release of serotonin and catecholamines by drugs. Pharmacol Rev. 1962 Dec;14:531–550. [PubMed] [Google Scholar]
  19. Schwartz A., Askenase P. W., Gershon R. K. The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J Immunol. 1977 Jan;118(1):159–165. [PubMed] [Google Scholar]
  20. Sprent J. Circulating T and B lymphocytes of the mouse. I. Migratory properties. Cell Immunol. 1973 Apr;7(1):10–39. doi: 10.1016/0008-8749(73)90180-9. [DOI] [PubMed] [Google Scholar]
  21. Stitzel R. E. The biological fate of reserpine. Pharmacol Rev. 1976 Sep;28(3):179–208. [PubMed] [Google Scholar]
  22. Thomas W. R., Schrader J. W. Delayed hypersensitivity in mast-cell-deficient mice. J Immunol. 1983 Jun;130(6):2565–2567. [PubMed] [Google Scholar]
  23. Zatz M. M., Lance E. M. The distribution of 51Cr-labeled lymphocytes into antigen-stimulated mice. Lymphocyte trapping. J Exp Med. 1971 Jul 1;134(1):224–241. doi: 10.1084/jem.134.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES